VKH
IRD

Virtu KCG Holdings’s Opus Genetics IRD Stock Holding History

Virtu KCG Holdings’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-44
Closed -$11K – 3588
2017
Q1 		$11K Buy
44
+13
+42% +$1.69K ﹤0.01% 3021
2016
Q4 		$2K Sell
31
-201
-87% -$16.4K ﹤0.01% 3341
2016
Q3 		$23K Sell
232
-145
-38% -$17.5K ﹤0.01% 2909
2016
Q2 		$45K Buy
377
+44
+13% +$6.17K ﹤0.01% 2695
2016
Q1 		$53K Buy
333
+35
+12% +$5.83K ﹤0.01% 2452
2015
Q4 		$52K Sell
298
-70
-19% -$14.9K ﹤0.01% 3150
2015
Q3 		$92K Buy
368
+77
+26% +$20.9K ﹤0.01% 2853
2015
Q2 		$85K Buy
291
+263
+939% +$89.3K ﹤0.01% 2960
2015
Q1 		$10K Sell
28
-695
-96% -$252K ﹤0.01% 3008
2014
Q4 		$243K Buy
723
+553
+325% +$191K ﹤0.01% 2632
2014
Q3 		$66K Buy
170
+125
+278% +$45K ﹤0.01% 3282
2014
Q2 		$19K Sell
45
-592
-93% -$269K ﹤0.01% 3532
2014
Q1 		$331K Buy
+637
New +$344K ﹤0.01% 2403
2013
Q4 		– Sell
-152
Closed -$33K – 4332
2013
Q3 		$33K Buy
+152
New +$35.5K ﹤0.01% 3562

Other funds holding IRD

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Virtu KCG Holdings's IRD Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Opus Genetics (IRD) in Q2 2017, closing a stake of 44 shares — an estimated $11K sold.

Virtu KCG Holdings first reported a position in IRD in Q3 2013 and held it in 14 quarters. The position peaked at $331K in Q1 2014. 23 funds tracked by Wall St. Rank hold IRD as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Opus Genetics position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 44 Opus Genetics shares in Q2 2017, an estimated $11K.
  • Virtu KCG Holdings first reported a position in Opus Genetics in Q3 2013 and held it in 14 quarters.
  • Virtu KCG Holdings's Opus Genetics position peaked at $331K in Q1 2014.
  • 23 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.